Skip to search boxSkip to navigationSkip to main content

Up-regulation of c-Jun-NH2-kinase pathway contributes to the induction of mitochondria-mediated apoptosis by α-tocopheryl succinate in human prostate cancer cells

  • Ke Zu
    ,
  • Lesleyann Hawthorn
    ,
  • Clement Ip(corresponding author)
*Corresponding author for this work
  • Roswell Park Cancer Institute
Scholary Output:
Contribution to journal
Article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Previously, α-tocopheryl succinate (α-TOS) has been reported to induce caspase-mediated apoptosis in PC-3 human prostate cancer cells. Caspase-9 was among several initiator caspases activated by α-TOS, suggesting a potential contribution of the intrinsic apoptotic pathway in mediating the response to α-TOS. Gene expression microarray was carried out as a screen to identify novel signaling molecules modulated by α-TOS, with a special focus on those known to play a role in mitochondria-mediated apoptosis. We discovered that Ask1, GADD45β, and Sek1, three key components of the stress-activated mitogen-activated protein kinase pathway, are novel targets of α-TOS. Western blot analysis showed increased levels of phospho-Sek1 and phospho-c-Jun-NH2-kinase (JNK) in addition to total Ask1, GADD45β, and Sek1. α-TOS also altered JNK-specific phosphorylation of Bcl-2 and Bim in a manner consistent with enhanced mitochondrial translocation of Bax and Bim. Because the expression level of most Bcl-2 family members remained unchanged, the posttranslational modification of Bcl-2 and Bim by JNK is likely to be a driving force in α-TOS activation of the intrinsic apoptotic pathway. Based on our findings, we propose working model to capture the salient features of the poptotic signaling circuitry of α-TOS.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 43-50 (8 pages)

Journal (Volume, Issue Number)

Molecular cancer therapeutics (Volume 4, Issue 1)

Publication milestones

  • Published - 01/2005

Publication status

Published - 01/2005

ISSN

1535-7163

Publication IDs

  • Scopus: 13944274587
  • PubMed: 15657352

Publication metrics

Metrics

SciVal
FWCI
2.18
SciVal
Author count
3
SciVal
citations
63
SciVal
Paper percentile
90
SciVal
Top percentile
10
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
66
Captures
14

Funding Details

FunderFunding number
NCI
P30CA016056